title: Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale.
abstract: OBJECTIVE
  To assess organ involvement according to a modified Medsger severity scale and its relation to outcome and prognosis in patients with systemic sclerosis.
  
  
  METHODS
  One hundred consecutive patients observed in Lund with systemic sclerosis were followed up for a period of 14 years. The mean follow up time was 7.7 years. Initial assessment and an annual evaluation was performed for each patient, with a mean visit frequency of 5.6 per patient.
  
  
  RESULTS
  Age at referral, high total skin score, truncal skin involvement, low vital capacity, low static lung compliance, low Cr-EDTA clearance, and ECG abnormalities at the initial assessment predict poor outcome. A severity scoring system for five organ systems indicates a slow progression of organ dysfunction after recruitment into the study. The female: male ratio was 2:1, the mean age at onset of symptoms was 42.3 (range 3-82), and the mean age at recruitment was 47.2 years (range 17-82). Thirty patients died during the follow up period at the mean age of 61.3 years (range 33-85). The causes of death were directly related to systemic sclerosis in at least 10 patients, infections in six, cancers in nine, and other causes in four patients. The standardised mortality ratio was 3.5 and 3.7 for men and women, respectively.
  
  
  CONCLUSIONS
  A high severity score for function of vital organs was shown to predict shortened survival. In this study a severity score based on simple clinical assessment variables was able to predict poor outcome from extensive skin changes, ECG changes, and compromised lung and renal function. Organ dysfunction mainly became manifest during the first five years of the disease, whereafter organ function remained largely stable.
authors.affiliation: Department of Rheumatology, University Hospital, Lund, Sweden. arnijon@rsp.is
authors.forename: A J
authors.initials: AJ
authors.lastname: Geirsson
authors.forename: F A
authors.initials: FA
authors.lastname: Wollheim
authors.forename: A
authors.initials: A
authors.lastname: Akesson
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D004064:Digestive System / Q000503:physiopathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D015656:Respiratory Mechanics; D012595:Scleroderma, Systemic / Q000401:mortality / Q000503:physiopathology*; D012720:Severity of Illness Index; D015996:Survival Rate